<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201117049426N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-22</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of counseling on quality of life and self-care behaviors of pregnant women with hypertension</public_title>
      <acronym></acronym>
      <scientific_title>The effect of self-care counseling on quality of life and self-care behaviors in pregnant women with hypertension</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-05-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52390</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Sample allocation to two classes (gestational hypertension - chronic hypertension) is using double blocks. Random allocation in each class will be by using the site www.randomization.com and using double blocks 45 The sample (separated by half of the sample size in the control and intervention group for each of the cities of Mashhad and Sabzevar) is randomly assigned to both intervention and control groups. The numbers of individuals and the relevant group are specified. We put the name of the related group in the envelope and the numbers related to it on the envelope. The numbered envelopes are then sorted from one to n, and the individuals remove the envelope entry, respectively, and to the group inside the envelope marked with the letters A (intervention) and B (control), the Allocation Concealment allocation method: Sealed envelopes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Hypertension. Condition 2: Hypertension in pregnancy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: In the intervention group, patients with a gestational age of 24 to 32 weeks participate in the intervention group in 4 group counseling sessions that will be held by the researcher every week in health centers. Each session will be held for 45 to 60 minutes. Counseling sessions will be held in groups with 4 to 6 pregnant mothers, mothers in the same group in the first counseling session, in subsequent sessions will be in the same group. Considered for a quiet and private environment and counseling will be done in the form of GATHER counseling steps (Greet, Ask, Tell, Help, Explain, Return). In group counseling sessions, you will first introduce your counselor to the group and share information about their expertise and experiences with clients. He then asks each member to introduce themselves. The consultant will then explain the purpose of forming the group and their duties and those of the group members. The goals of counseling will include identifying mothers 'problems with self-care, prioritizing them, reviewing existing solutions to their problems, their advantages and disadvantages, and deciding on mothers' free choice of self-care behaviors. The role of the guidance counselor will be to encourage group participation and facilitation. The group rules process will be introduced by the counselor and the counselor will seek to establish a therapeutic relationship that will be accomplished with the skills of listening, empathy, understanding emotions, empathy, companionship, attention, and other techniques. Description: Session 1: Greetings, greeting pregnant mothers and asking open-ended questions, group Q&amp;A with mothers about their own problems and needs, identifying misconceptions and beliefs about physical, mental and behavioral health Self-care and encouraging them to think about ways to reduce the risk to the mother and fetus. (G and A) In this session, the counselor asks mothers to take turns presenting their problems in a problem-oriented manner, and members comment on it. And comment on problems with the help of brainstorming. The list of mothers' problems is compiled by the counselor. Session 2: Providing self-care counseling based on the needs and problems of mothers, and providing information to pregnant mothers about the proper diet of these mothers (low-salt and low-fat diet, fruit consumption and Green leafy vegetables contain potassium fiber, magnesium, etc.), proper physical activity in them, stress management and improving relationships between these mothers in interaction with family and relatives, strengthening self-care awareness and effective ways to reduce maternal and fetal risks. . (T). Session 3: Helping to freely choose the best self-care behaviors. In this session, the counselor will use group problem-solving techniques to explore possible solutions to the remaining problems of mothers and prioritize them, and the best solution for correct self-care behaviors will be freely selected by mothers. (H) Session 4: The counselor will strengthen awareness and review the content, explain to the mother about how to use the correct self-care behaviors according to the individual needs of mothers. Also in the fourth session, follow-up times and weekly contacts with mothers will be explained (E and R) two weeks later. At the end of the counseling sessions, a 36-item quality of life questionnaire and a self-care questionnaire in patients with hypertension (HTN-SCP) as a post-test with the aim of assessing the researcher's success in conducting self-care counseling and answering potential problems and questions by units. Intervention 2: Control group: The control group will also receive routine pregnancy care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals

When:
Access period starts 6 months after the results are published

To whom:
Researchers and students of academic institutions

Conditions:
Based on the present study and without changes in the data

Where to obtain:
Contact the author responsible for response via email or phone:
golnazahmadi56@gmail.com Tel: 44665881 51 0098

How to obtain:
The request for access to data / documents will be reviewed by the research team

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Golnaz Sadat Ahmadinezhad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khorasan Razavi, Mashhad, Daneshgah St., Ph.D. Intersection, Ibn Sina St., School of Nursing and Midwifery</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Ahmadinezhadg982@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Talaat Khadivzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khorasan Razavi, Mashhad, Daneshgah St., Ph.D. Intersection, Ibn Sina St., School of Nursing and Midwifery</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Tkhadivzadeh@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Written informed consent to participate in the research
Being a pregnant woman
Being Iranian and living in Mashhad
Age over 18 years
Medical diagnosis of gestational hypertension by measuring systolic blood pressure greater than or equal to 140 mm Hg or diastolic blood pressure greater than 90 mm Hg more than twice or mild preeclampsia in the 20th week of pregnancy
Diagnosis of mild preeclampsia or gestational hypertension above 140/90 mm Hg without serious complications
Medical diagnosis of chronic hypertension by measuring systolic blood pressure greater than or equal to 140 mm Hg or diastolic blood pressure greater than 90 mm Hg more than twice measured before pregnancy
No drug addiction No serious medical and obstetric problems and complications
No underlying illnesses that require constant medication
Ability to communicate verbally, have a minimum literacy
Having a phone number to call and want to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having serious medical and midwifery complications that require medical and pharmacological interventions
Hospitalization and termination of pregnancy due to high blood pressure
Severe preeclampsia and eclampsia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I10</hc_code>
      <hc_code>O13</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Essential (primary) hypertension</hc_keyword>
      <hc_keyword>Gestational [pregnancy-induced] hypertension without significant proteinuria</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: In the intervention group, patients with a gestational age of 24 to 32 weeks participate in the intervention group in 4 group counseling sessions that will be held by the researcher every week in health centers. Each session will be held for 45 to 60 minutes. Counseling sessions will be held in groups with 4 to 6 pregnant mothers, mothers in the same group in the first counseling session, in subsequent sessions will be in the same group. Considered for a quiet and private environment and counseling will be done in the form of GATHER counseling steps (Greet, Ask, Tell, Help, Explain, Return). In group counseling sessions, you will first introduce your counselor to the group and share information about their expertise and experiences with clients. He then asks each member to introduce themselves. The consultant will then explain the purpose of forming the group and their duties and those of the group members. The goals of counseling will include identifying mothers 'problems with self-care, prioritizing them, reviewing existing solutions to their problems, their advantages and disadvantages, and deciding on mothers' free choice of self-care behaviors. The role of the guidance counselor will be to encourage group participation and facilitation. The group rules process will be introduced by the counselor and the counselor will seek to establish a therapeutic relationship that will be accomplished with the skills of listening, empathy, understanding emotions, empathy, companionship, attention, and other techniques. Description: Session 1: Greetings, greeting pregnant mothers and asking open-ended questions, group Q&amp;A with mothers about their own problems and needs, identifying misconceptions and beliefs about physical, mental and behavioral health Self-care and encouraging them to think about ways to reduce the risk to the mother and fetus. (G and A) In this session, the counselor asks mothers to take turns presenting their problems in a problem-oriented manner, and members comment on it. And comment on problems with the help of brainstorming. The list of mothers' problems is compiled by the counselor. Session 2: Providing self-care counseling based on the needs and problems of mothers, and providing information to pregnant mothers about the proper diet of these mothers (low-salt and low-fat diet, fruit consumption and Green leafy vegetables contain potassium fiber, magnesium, etc.), proper physical activity in them, stress management and improving relationships between these mothers in interaction with family and relatives, strengthening self-care awareness and effective ways to reduce maternal and fetal risks. . (T). Session 3: Helping to freely choose the best self-care behaviors. In this session, the counselor will use group problem-solving techniques to explore possible solutions to the remaining problems of mothers and prioritize them, and the best solution for correct self-care behaviors will be freely selected by mothers. (H) Session 4: The counselor will strengthen awareness and review the content, explain to the mother about how to use the correct self-care behaviors according to the individual needs of mothers. Also in the fourth session, follow-up times and weekly contacts with mothers will be explained (E and R) two weeks later. At the end of the counseling sessions, a 36-item quality of life questionnaire and a self-care questionnaire in patients with hypertension (HTN-SCP) as a post-test with the aim of assessing the researcher's success in conducting self-care counseling and answering potential problems and questions by units</i_keyword>
      <i_keyword>Control group: The control group will also receive routine pregnancy care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life: The meaning of quality of life in this study is the score obtained from the quality of life questionnaire (sf-36) which has 36 questions and consists of 8 subscales and each subscale consists of 2 to 10 items. The eight subscales of this questionnaire are: Physical Function (PF), Role for Physical Health (RP), Role for Emotional Health (RE), Energy / Fatigue (EF), Emotional Well-Being (EW), Social Function (SF), Pain (P) and general health (GH). Also, from the integration of subscales, two general subscales are obtained, namely physical health and mental health. In this questionnaire, a lower score indicates a lower quality of life and vice versa. Timepoint: The time periods for measuring the quality of life variable score at the beginning of the study and 2 weeks after the end of the weekly self-care counseling. Method of measurement: Quality of Life Questionnaire (SF-36): It has 36 questions and consists of 8 subscales and each subscale consists of 2 to 10 items. The eight subscales of this questionnaire are: Physical Function (PF), Role for Physical Health (RP), Role for Emotional Health (RE), Energy / Fatigue (EF), Emotional Well-Being (EW), Social Function (SF), Pain (P) and general health (GH). Also, by merging the subscales, two general subscales with the names of physical health and mental health are obtained. In this questionnaire, a lower score indicates a lower quality of life and vice versa. How to score in this questionnaire is as follows: physical function with 10 3-choice questions, role disorder due to physical health with 4 2-choice questions, role disorder due to mental health with 3 two-choice questions, feeling of vitality with 4 6-choice questions O, mental function or 5 6-choice questions, social functioning with 2 5-choice questions, feeling of pain and disability with 2 5-choice questions, and general health feeling with 5 5-choice questions and a question related to emotion There is also a health change that is not included in any of the dimensions of the questionnaire and is only added to the total score. The scale score of the items in this questionnaire is between 1 and 5. The range of scores of this questionnaire is between 0 and 100, and a higher score indicates a better quality of life.</prim_outcome>
      <prim_outcome>Self-care behaviors: Self-care behaviors are the sum of conscious, learned and purposeful actions and activities that a person does to maintain life and promote the health of himself and his family. Timepoint: Periods of self-care behavioral scores were measured at the beginning of the study and 2 weeks after the end of the weekly self-care consultation to evaluate the success of the intervention. Method of measurement: Self-care questionnaire in patients with hypertension (HTN-SCP): will have 20 items in 4 areas of diet with 8 items, medication diet 5 items, attention to food label 2 items and disease management 5 items. Answers in the form of four-point Likert will always be (score 4), often (score 3), sometimes (score 2) and very little / never (score 1). The maximum score of the items will be 80 and the minimum will be 20. A higher score indicates better self-care behavior and a lower score indicates poor self-care behavior.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-02-23</approval_date>
        <contact_name>Ethics committee of  Mashhad  University of Medical Sciences</contact_name>
        <contact_address>Khorasan Razavi, Mashhad, Daneshgah St., Ph.D. Intersection, Ibn Sina St., School of Nursing and Midwifery Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
